2.Extended-Duration Treatment of Superficial Vein Thrombosis of the Lower Limbs with Tinzaparin
Konstantinos M NIKOLAKOPOULOS ; Stavros K KAKKOS ; Chrysanthi P PAPAGEORGOPOULOU ; Ioannis A TSOLAKIS
Vascular Specialist International 2018;34(1):1-9
PURPOSE: To identify risk factors for recurrent thromboembolic events (RTEs) and define the optimum duration of treatment with tinzaparin in patients with superficial vein thrombosis (SVT) of the lower limbs. MATERIALS AND METHODS: A total of 147 consecutive patients with significant SVT were treated with subcutaneously administered tinzaparin. The composite primary endpoint of the study was RTE, deep-vein thrombosis (DVT) and/or pulmonary embolism (PE) at 120 days. Patients were stratified into group A, where patients received a variable dose of tinzaparin for up to 60 days (n=98), and a subsequent group B-ext, where patients received a standardized intermediate dose of tinzaparin (n=49) for 90 days. RESULTS: RTEs occurred in 15/147 patients (10.2%), including recurrent SVT (n=10), DVT (n=4) and fatal PE (n=1). RTEs were less frequent in group B-ext (0% vs. 15.3% for group A, P=0.004), a difference that remained significant at the one-year follow-up. Clinically extensive SVT was an independent predictor for RTEs (hazard ratio, 5.94; 95% confidence interval, 2.05–17.23; P=0.001, Cox regression). Predictors or DVT or PE in group A included clinically extensive SVT (P=0.004), absence of local pain (P=0.023) and the ultrasound findings of superficial axial vein thrombosis (any, P=0.006 or isolated, P=0.036) and multiple thrombosed superficial venous sites (P < 0.001). CONCLUSION: An extended three-month regimen of tinzaparin in patients with SVT of the lower limbs is more effective than a shorter course and may be desirable in patients with risk factors.
Follow-Up Studies
;
Heparin
;
Humans
;
Lower Extremity
;
Pulmonary Embolism
;
Recurrence
;
Risk Factors
;
Thrombophlebitis
;
Thrombosis
;
Ultrasonography
;
Veins
;
Venous Thrombosis
3.Vacuum-Assisted Thrombo-Aspiration for Paradoxical Embolism in Left Renal Artery:A Case Report and Literature Review
Dimitrios DIAMANTOPOULOS-KOGKAS ; Pavlos GEORGIOU ; Christos PITROS ; Chrysanthi PAPAGEORGOPOULOU ; Marios PAPASOTIRIOU ; Nikolaos KARYDIS ; Nikolaos KOUTSOYIANNIS ; Athina MOUGIOU ; Konstantinos KATSANOS ; Spyros PAPADOULAS
Vascular Specialist International 2024;40(2):21-
Paradoxical embolism through the foramen ovale is a rare and devastating event requiring urgent treatment. Herein, we present the case of a 23-year-old male who presented with a pulmonary embolism complicated by a left renal artery paradoxical embolism. Urgent vacuum-assisted thrombo-aspiration restored normal perfusion of the left kidney within 5 hours. The patient had a patent foramen ovale and heterozygous thrombophilia. However, a radioisotopic scan performed 2 years later revealed an unexpected decrease in left renal perfusion. Therefore, despite the angiographic success, functional evaluation using a renal scan should be performed to assess renal function.